Figure S9 from AREG and EREG Are Predictive Biomarkers of Response to EGFR Inhibition in Gastroesophageal Cancer

Key Points

Increased AREG or EREG overexpression correlates with improved overall survival in cancer patients.
Key evidence shows that higher levels of AREG or EREG significantly enhance patient outcomes in the ACRG cohort.
Observational analysis utilized data from the ACRG cohort to assess the impact of biomarkers on survival rates in cancer patients.
Findings emphasize the importance of identifying predictive biomarkers in improving treatment responses for patients with gastroesophageal cancer.

We only have this paper's title and publication details.

Analysis examines overall survival linked to AREG or EREG overexpression in gastroesophageal cancer, suggesting their potential as biomarkers.

Overall survival according AREG or EREG overexpression in ACRG cohort.

No takes yet. Share an insight, caveat, or question.

Conticelli et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Share